About Us
Overview
Functions
Legislation
Management
The Board
e-services
Guidelines
Forms
Registers
Fees
Media Centre
News
Press Releases
Careers
Publications
Tenders
Contact
About Us
Overview
Functions
Legislation
Management
The Board
e-services
Guidelines
Forms
Registers
Fees
Media Centre
News
Press Releases
Careers
Publications
Tenders
Contact
Projects
ZAMRA
Projects
Medical Product Advisory : FALSIFIED OZEMPIC® IN CIRCULATION
Medical Product Advisory : FALSIFIED OZEMPIC® IN CIRCULATION
November 9, 2023
Print
Projects
Advisory_Falsified Ozempic_07112023
Download
ALERTS AND PRODUCT RECALLS
View Detail
MEDICAL PRODUCT ALERT NO. 3/2024: FALSIFIED (CONTAMINATED) OXYMORPHONE HYDROCHLORIDE 40MG TABLETS IDENTIFIED IN THE WHO REGION FOR EUROPE
ZAMRA Medical_Product_Alert_3_2024Download
Medical Product Alert
View Detail
MEDICAL PRODUCT ALERT : RECALL OF FUROSEMIDE TABLETS BP 40MG BATCH NO. TFR222001 – SKYLARK
ZAMRA Alert_Recall_Furosemide Tablets_BN TFR222001_Skylark_31072024Download
Home
About Us
e-services
Guidelines
Registers
Newsroom
Fees
Forms
Contact
Search for:
About Us
Overview
Functions
Legislation
Management
The Board
e-services
Guidelines
Forms
Registers
Fees
Media Centre
News
Press Releases
Careers
Publications
Tenders
Contact